Compare PSO & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSO | ALGN |
|---|---|---|
| Founded | 1844 | 1997 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Books | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 10.5B |
| IPO Year | 2000 | 2000 |
| Metric | PSO | ALGN |
|---|---|---|
| Price | $17.24 | $163.41 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 16 |
| Target Price | $16.15 | ★ $186.50 |
| AVG Volume (30 Days) | 804.5K | ★ 1.0M |
| Earning Date | 02-25-2027 | 10-28-2026 |
| Dividend Yield | ★ 1.98% | N/A |
| EPS Growth | N/A | ★ 0.53 |
| EPS | N/A | ★ 4.98 |
| Revenue | N/A | ★ $387,126,000.00 |
| Revenue This Year | $4.10 | $2.24 |
| Revenue Next Year | $5.36 | $3.04 |
| P/E Ratio | ★ $14.05 | $33.11 |
| Revenue Growth | N/A | ★ 23.95 |
| 52 Week Low | $12.02 | $130.23 |
| 52 Week High | $18.43 | $200.44 |
| Indicator | PSO | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 48.34 | 63.09 |
| Support Level | $15.80 | $151.31 |
| Resistance Level | $17.70 | $182.05 |
| Average True Range (ATR) | 0.29 | 5.51 |
| MACD | -0.12 | 1.49 |
| Stochastic Oscillator | 16.55 | 85.30 |
UK-listed Pearson is a testing and educational provider. Pearson's primary operations are in assessment and qualifications, testing and higher education, but they also provide English education and testing, virtual learning, prehiring testing and screening, and upskilling/reskilling. The company divested noncore businesses, including the Financial Times, The Economist, and the publishing house Penguin, and is now focused on serving as an educational resource and testing provider.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.